Insights into enhancing the chemosensitivity of human tumors: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppreses the expression of cell-cycle kinases WEE1 and CHK1 via up regulation of its target gene, 17/April/2014, 6.29 am

Insights into enhancing the chemosensitivity of human tumors: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppreses the expression of cell-cycle kinases WEE1 and CHK1 via up regulation of its target gene, 17/April/2014, 6.29 am

Insights into enhancing the chemosensitivity of human tumors: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppreses the expression of cell-cycle kinases WEE1 and CHK1 via up regulation of its target gene, 17/April/2014, 6.29 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Insights into enhancing the chemosensitivity of human tumors: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppreses the expression of cell-cycle kinases WEE1 and CHK1 via up regulation of its target gene, 17/April/2014, 6.29 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing